How many sites should an orthopedic trauma prospective multicenter trial have? A marginal analysis of the Major Extremity Trauma Research Consortium completed trials.

Authors:
Allen L; O'Toole RV; Bosse MJ; Obremskey WT; Archer KR and 7 more

Journal:
Trials

Publication Year: 2024

DOI:
10.1186/s13063-024-07917-0

PMCID:
PMC10840249

PMID:
38317256

Journal Information

Full Title: Trials

Abbreviation: Trials

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll the underlying trials analyzed were approved by an IRB at the corresponding author’s home institution: Johns Hopkins Bloomberg School of Public Health (IRB: FWA 00000287). Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This work was supported by the Department of Defense Peer Reviewed Orthopaedic Research Program [grant numbers W81XWH-09-2-0108, W81XWH-10-2-0090, W81XWH-12-1-0588, W81XWH-10-2-0134, W81XWH-15-2-0074, W81XWH-10-2-0133] and the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [grant number R01AR064066]. The funding bodies had no role in writing the manuscript or in the design of the study and collection, analysis, and interpretation of the data."

Evidence found in paper:

"Trial registration Please see Table 1 for individual trial registration numbers and dates of registration."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025